Zevra Therapeutics Insider Trades
NASDAQ: ZVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 13 · $2.52M
- Shares bought / sold
- 0 / 244.18K
- Net activity
- Net selling $2.5 million
Zevra Therapeutics insider activity
Over the last 12 months, Zevra Therapeutics insiders reported 28 transactions on SEC Form 4: 0 open-market purchases and 13 sales. Insiders bought $0 and sold $2.5 million worth of stock, for net insider selling of $2.5 million. The largest seller was McFarlane Neil F., with $1.2 million in reported sales.
The most recent filing shows McFarlane Neil F. (President and CEO) selling 20,000 shares at $11.25 on Oct 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ZVRA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ZVRA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 12, 2026 | McFarlane Neil F.President and CEO | Sale | 20,000 | $224.95K | Form 4 |
| Oct 10, 2026 | McFarlane Neil F.President and CEO | Option exercise | 50,000 | — | Form 4 |
| Aug 14, 2026 | Thompson RahsaanChief Legal & Compliance | Sale | 42,666 | $474.77K | Form 4 |
| Aug 10, 2026 | Watton Corey MichaelDirector | Sale | 12,300 | $138.38K | Form 4 |
| Aug 10, 2026 | Watton Corey MichaelDirector | Option exercise | 12,300 | $61.13K | Form 4 |
| Jun 22, 2026 | Thompson RahsaanChief Legal & Compliance | Sale | 34,557 | $438.30K | Form 4 |
| Jun 21, 2026 | Thompson RahsaanChief Legal & Compliance | Option exercise | 66,667 | — | Form 4 |
| May 11, 2026 | Thompson RahsaanChief Legal & Compliance | Sale | 1,794 | $20.27K | Form 4 |
| Mar 24, 2026 | Bode John BDirector | Option exercise | 39,200 | $191.69K | Form 4 |
| Mar 24, 2026 | Bode John BDirector | Option exercise | 39,200 | $194.82K | Form 4 |
| Feb 9, 2026 | McFarlane Neil F.President and CEO | Sale | 14,625 | $125.19K | Form 4 |
| Feb 7, 2026 | McFarlane Neil F.President and CEO | Option exercise | 37,500 | — | Form 4 |
| Feb 3, 2026 | Sangiovanni Timothy J.SVP, Finance & Corp Controller | Sale | 3,000 | $27.55K | Form 4 |
| Feb 3, 2026 | Schafer JoshuaCCO | Sale | 10,500 | $96.50K | Form 4 |
| Feb 2, 2026 | McFarlane Neil F.President and CEO | Sale | 91,000 | $853.43K | Form 4 |
| Jan 31, 2026 | McFarlane Neil F.President and CEO | Option exercise | 233,334 | — | Form 4 |
| Jan 31, 2026 | Sangiovanni Timothy J.SVP, Finance & Corp Controller | Option exercise | 11,666 | — | Form 4 |
| Jan 31, 2026 | Schafer JoshuaCCO | Option exercise | 35,334 | — | Form 4 |
| Jan 30, 2026 | Quartel Adrian WChief Medical Officer | Sale | 4,533 | $40.04K | Form 4 |
| Jan 30, 2026 | Quartel Adrian WChief Medical Officer | Option exercise | 11,333 | — | Form 4 |
| Jan 30, 2026 | Thompson RahsaanChief Legal & Compliance | Sale | 4,080 | $36.01K | Form 4 |
| Jan 30, 2026 | Thompson RahsaanChief Legal & Compliance | Option exercise | 11,333 | — | Form 4 |
| Jan 30, 2026 | Sangiovanni Timothy J.SVP, Finance & Corp Controller | Sale | 1,750 | $15.44K | Form 4 |
| Jan 30, 2026 | Sangiovanni Timothy J.SVP, Finance & Corp Controller | Option exercise | 6,333 | — | Form 4 |
| Jan 30, 2026 | Schafer JoshuaCCO | Sale | 3,375 | $29.80K | Form 4 |
| Jan 30, 2026 | Schafer JoshuaCCO | Option exercise | 11,333 | — | Form 4 |
| Dec 31, 2025 | Clifton R. LaDuaneFormer CFO & Treasurer | Tax withholding | 48,513 | $434.68K | Form 4 |
| Dec 31, 2025 | Clifton R. LaDuaneFormer CFO & Treasurer | Option exercise | 140,667 | — | Form 4 |
| Oct 10, 2025 | McFarlane Neil F.President and CEO | Sale | 19,500 | $210.91K | Form 4 |
| Oct 10, 2025 | McFarlane Neil F.President and CEO | Option exercise | 50,000 | — | Form 4 |
| Sep 12, 2025 | Shih AlvinDirector | Buy | 20,000 | $157.80K | Form 4 |
| Sep 12, 2025 | FAVORITO TAMARA ADirector | Buy | 3,175 | $24.72K | Form 4 |
| Aug 19, 2025 | Bode John BDirector | Buy | 5,000 | $45.83K | Form 4 |
| Jun 26, 2025 | Thompson RahsaanChief Legal & Compliance | Sale | 24,000 | $221.00K | Form 4 |
| Jun 21, 2025 | Thompson RahsaanChief Legal & Compliance | Option exercise | 66,666 | — | Form 4 |
| Mar 28, 2025 | Watton Corey MichaelDirector | Buy | 300 | $2.35K | Form 4 |
| Mar 19, 2025 | Bode John BDirector | Buy | 10,000 | $79.62K | Form 4 |
| Feb 13, 2025 | Sangiovanni Timothy J.SVP, Finance & Corp Controller | Sale | 3,000 | $23.59K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4